JP2005519095A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519095A5 JP2005519095A5 JP2003572556A JP2003572556A JP2005519095A5 JP 2005519095 A5 JP2005519095 A5 JP 2005519095A5 JP 2003572556 A JP2003572556 A JP 2003572556A JP 2003572556 A JP2003572556 A JP 2003572556A JP 2005519095 A5 JP2005519095 A5 JP 2005519095A5
- Authority
- JP
- Japan
- Prior art keywords
- maltitol
- cariogenic
- insensitive
- sweet
- diluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200657A SE0200657D0 (sv) | 2002-03-04 | 2002-03-04 | Novel Formulation |
| PCT/SE2003/000371 WO2003074036A1 (en) | 2002-03-04 | 2003-03-03 | Novel formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519095A JP2005519095A (ja) | 2005-06-30 |
| JP2005519095A5 true JP2005519095A5 (https=) | 2006-04-20 |
Family
ID=20287162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003572556A Withdrawn JP2005519095A (ja) | 2002-03-04 | 2003-03-03 | 新規製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050152847A1 (https=) |
| EP (1) | EP1487423A1 (https=) |
| JP (1) | JP2005519095A (https=) |
| AU (1) | AU2003217110A1 (https=) |
| SE (1) | SE0200657D0 (https=) |
| WO (1) | WO2003074036A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060293293A1 (en) * | 2003-05-22 | 2006-12-28 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
| US20070099883A1 (en) * | 2005-10-07 | 2007-05-03 | Cheryl Lynn Calis | Anhydrous mometasone furoate formulation |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| WO2009026434A1 (en) * | 2007-08-21 | 2009-02-26 | Alkermes, Inc. | Pulmonary pharmaceutical formulations |
| EP2214679B1 (en) | 2007-11-13 | 2019-03-27 | Meritage Pharma, Inc. | Corticosteroid compositions |
| US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| US20090143343A1 (en) * | 2007-11-13 | 2009-06-04 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| US20090264392A1 (en) * | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
| WO2014175253A1 (ja) * | 2013-04-22 | 2014-10-30 | 株式会社栃木臨床病理研究所 | 抗腫瘍剤 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2588005B1 (fr) * | 1985-10-02 | 1987-12-11 | Roquette Freres | Maltitol poudre directement compressible et son procede de preparation |
| SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| US5747445A (en) * | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| SE9700136D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| SE9700134D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| SE9404468D0 (sv) * | 1994-12-22 | 1994-12-22 | Astra Ab | Powder formulations |
| US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
| US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| JP4691298B2 (ja) * | 1999-10-12 | 2011-06-01 | 科研製薬株式会社 | 粉末吸入用製剤及びその製造方法 |
-
2002
- 2002-03-04 SE SE0200657A patent/SE0200657D0/xx unknown
-
2003
- 2003-03-03 AU AU2003217110A patent/AU2003217110A1/en not_active Abandoned
- 2003-03-03 US US10/506,590 patent/US20050152847A1/en not_active Abandoned
- 2003-03-03 WO PCT/SE2003/000371 patent/WO2003074036A1/en not_active Ceased
- 2003-03-03 EP EP03713142A patent/EP1487423A1/en not_active Withdrawn
- 2003-03-03 JP JP2003572556A patent/JP2005519095A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519095A5 (https=) | ||
| US7125564B2 (en) | Water soluble and palatable complexes | |
| JP5566408B2 (ja) | ドライシロップ剤 | |
| EP2893940A2 (en) | Granulated material for tablet that rapidly disintegrates in mouth | |
| CA2389349A1 (en) | Aerosol composition comprising formoterol | |
| JP2009510068A5 (https=) | ||
| JP2009532343A5 (https=) | ||
| ITMI971746A1 (it) | Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua | |
| WO2013125350A1 (ja) | 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠 | |
| CN101102748A (zh) | 具有感觉提示剂的在口中分裂的药物组合物 | |
| EP3427732A1 (en) | Instantly wettable oral film dosage form without surfactant or polyalcohol | |
| JP5630902B2 (ja) | ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法 | |
| JP2022088683A (ja) | 医薬組成物 | |
| JP5291324B2 (ja) | 口腔内崩壊錠 | |
| KR20110112304A (ko) | 붕괴성 및 용출성에 우수한 내복용 정제 | |
| JP2004043475A (ja) | 経口用セファロスポリン製剤 | |
| WO2015198483A1 (ja) | 賦形剤造粒物、及び錠剤 | |
| JPH0827033A (ja) | エリスリトール含有固形剤 | |
| JP6088848B2 (ja) | 賦形剤造粒物及びその製造方法、並びに錠剤 | |
| WO2010119851A1 (ja) | 口腔内崩壊錠 | |
| JP2005232072A (ja) | 高湿度及び低湿度下で安定なフィルム製剤及びフィルム食品 | |
| JP2009514857A5 (https=) | ||
| CN1717245A (zh) | 医药组合物 | |
| US20080227849A1 (en) | Orally Disintegrable Solid Preparation Comprising Povidone-Iodine | |
| KR20060051486A (ko) | 의약적 냉각 에멀젼 |